Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Combination therapy with fesoterodine and doxazosin improves bladder function and delays BPH progression.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

Finasteride use linked to increased risk of sexual dysfunction, especially in younger people.

Tofacitinib, a hair regrowth treatment, may worsen acne.

Treatments for Frontal Fibrosing Alopecia have not been proven effective.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Frontal Fibrosing Alopecia involves disrupted cholesterol pathways, fibrosis, and increased mast cells.

Baricitinib may help treat frontal fibrosing alopecia and facial papules.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

Fexofenadine may help treat a difficult type of hair loss.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

Targeting immune pathways like JAK/STAT may help treat frontal fibrosing alopecia.

Digoxin is linked to a higher risk of anemia in patients with atrial fibrillation and heart failure.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

The research suggests Dutasteride and Solifenacin may be effective against the bacterium causing listeriosis.

Scientists found new, better-working inhibitors for a hormone-related enzyme.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Early diagnosis and treatment of EGFR inhibitor-induced folliculitis decalvans can prevent permanent hair loss.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

Farudodstat can prevent hair follicle immune damage linked to alopecia areata.

Tofacitinib can help regrow hair in about 50% of people with moderate-severe alopecia areata.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

Many drugs can cause lipid metabolism issues, and labels need better warnings.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.